Floatz logo

377 assets in Pancreatic Neoplasm

Therapeutic assets addressing Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
dn022150+ag　(stage ii)
Pancreatic Neoplasm
Jiangxi Kvvit Pharmaceutical Co., Ltd.P2/3CCC (48)
Enzalutamide
Pancreatic Neoplasm
Nuvation Bio Inc.P1/2CCC (48)
Intratumoral Mmr
Pancreatic Neoplasm
University of ArkansasP1/2CCC (48)
Iopamidol
Pancreatic Neoplasm
Masonic Cancer Center, University of MinnesotaP2CCC (48)
Regorafenib
Pancreatic Neoplasm
Incyte CorporationP2CCC (48)
Tadalafil
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CCC (48)
Trametinib
Pancreatic Neoplasm
Cancer Trials IrelandP2CCC (48)
2-CHLORO-N6-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE
Pancreatic Neoplasm
Can-Fite BioPharmaP2CC (46)
Agen1423
Pancreatic Neoplasm
Bruno BockornyP2CC (46)
ak130
Pancreatic Neoplasm
AkesoP2CC (46)
Antibody Drug Conjugate Composed Of A Humanized Monoclonal Antibody Targeting Cldn18.2 And Linker-Payload Mc-Vc-Pab-Mmae
Pancreatic Neoplasm
Shanghai Zhongshan HospitalP2CC (46)
Apsolol
Pancreatic Neoplasm
Zealand University HospitalP2CC (46)
Astragalus
Pancreatic Neoplasm
Shenzhen University General HospitalP2CC (46)
Bemalenograstim Alfa
Pancreatic Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CC (46)
Benmelstobart
Pancreatic Neoplasm
RenJi HospitalP2CC (46)
Blex 404
Pancreatic Neoplasm
Rgene CorporationP2CC (46)
Bms 986253
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CC (46)
dz-002
Pancreatic Neoplasm
Hoag Memorial Hospital PresbyterianP2CC (46)
Entrectinib
Pancreatic Neoplasm
Hoffmann-La RocheP2CC (46)
Ergotidine
Pancreatic Neoplasm
Sahlgrenska University HospitalP2CC (46)
Fruquintinib
Pancreatic Neoplasm
Fudan UniversityP2CC (46)
Genetically-Modified Oncolytic Type 5 Adenovirus Which Selectively Replicates In Tumor Cells Containing Dysfunctional P53 Gene (H101)
Pancreatic Neoplasm
Fudan UniversityP2CC (46)
Glipizide
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer CenterP2CC (46)
Hrs-7058
Pancreatic Neoplasm
Shandong Suncadia Medicine Co., Ltd.P2CC (46)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Pancreatic Neoplasm
Haihua YuanP2CC (46)
Jab-21822
Pancreatic Neoplasm
Allist Pharmaceuticals, Inc.P2CC (46)
Kras Tcr-Transduced Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)P2CC (46)
Levofolinic Acid
Pancreatic Neoplasm
Hopital FochP2CC (46)
Lomustine
Pancreatic Neoplasm
Actuate Therapeutics Inc.P2CC (46)
lt-002 (lactobacillus reuteri atg-f4
Pancreatic Neoplasm
Chungnam National University HospitalP2CC (46)
Motixafortide
Pancreatic Neoplasm
Gulam ManjiP2CC (46)
Pantoprazole
Pancreatic Neoplasm
Washington University School of MedicineP2CC (46)
Pd-L1 T-Hank
Pancreatic Neoplasm
ImmunityBio, Inc.P2CC (46)
Pegfilgrastim
Pancreatic Neoplasm
Australasian Gastro-Intestinal Trials GroupP2CC (46)
Pegph20
Pancreatic Neoplasm
Pancreatic Cancer Research TeamP2CC (46)
Resiquimod
Pancreatic Neoplasm
Institut BergoniéP2CC (46)
Romiplostim
Pancreatic Neoplasm
Peking University People's HospitalP2CC (46)
Shr-A1904
Pancreatic Neoplasm
Fudan UniversityP2CC (46)
Shr-A2102
Pancreatic Neoplasm
Fudan UniversityP2CC (46)
Streptozocin
Pancreatic Neoplasm
Gustave Roussy, Cancer Campus, Grand ParisP2CC (46)
tqb2916
Pancreatic Neoplasm
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P2CC (46)
Tretinoin
Pancreatic Neoplasm
Peking University People's HospitalP2CC (46)
Trilaciclib
Pancreatic Neoplasm
The Second Affiliated Hospital of Shandong First Medical UniversityP2CC (46)
Vebreltinib
Pancreatic Neoplasm
Apollomics Inc.P2CC (46)
Zanidatamab
Pancreatic Neoplasm
Haihua YuanP2CC (46)
Zentalis
Pancreatic Neoplasm
Brandon Huffman, MDP2CC (46)
Zolbetuximab
Pancreatic Neoplasm
Astellas Pharma Global Development, Inc.P2CC (46)
a2b543
Pancreatic Neoplasm
A2 Biotherapeutics Inc.P1/2CC (45)
a2b694
Pancreatic Neoplasm
A2 Biotherapeutics Inc.P1/2CC (45)
Adavosertib
Pancreatic Neoplasm
James Cleary, MD, PhDP2CC (45)
Showing 101 to 150 of 377 assets
PreviousPage 3 of 8Next